Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    METAPANC

    Peter Jo, Michael Ghadimi, Marie Crede, Tim Friede, Uwe Pelzer, Jens Siveke in Forum (2024)

  2. Article

    Open Access

    Visualization of deglutition and gastroesophageal reflux using real-time MRI: a standardized approach to image acquisition and assessment

    This study aims to develop a standardized algorithm for gastroesophageal image acquisition and diagnostic assessment using real-time MRI. Patients with GERD symptoms undergoing real-time MRI of the esophagus a...

    Lorenz Biggemann, Johannes Uhlig, Ulrike Streit, Omar Al-Bourini in Scientific Reports (2023)

  3. Article

    Open Access

    Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently needed for early disease detection, patient stratification for...

    David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück in npj Precision Oncology (2023)

  4. No Access

    Article

    Therapieempfehlung und Versorgung bei traumatischer Milzruptur

    Die Milz ist bei stumpfen abdominellen Traumata das am häufigsten betroffene Organ. Zur initialen Diagnostik gehören die körperliche Untersuchung, die laborchemische Kontrolle sowie die Sonographie. Im Weitere...

    Stina Schild-Suhren, Anne-Christine Zygmunt, Lorenz Biggemann in Die Chirurgie (2023)

  5. No Access

    Article

    Hepatic arterial infusion with nanoliposomal irinotecan leads to significant regression of tumor size of colorectal liver metastases in a CC531 rat model

    Long-term therapy for unresectable colorectal liver metastases remains challenging. Intraarterial treatments aim to avoid systemic adverse effects of chemotherapy. Nanoliposomal cytotoxic drugs manage to incre...

    Anne Kauffels, Hannah Nowack, Hanibal Bohnenberger in Clinical & Experimental Metastasis (2023)

  6. Article

    Open Access

    Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution

    Colorectal cancer liver metastases (CRCLM) are associated with a poor prognosis, reflected by a five-year survival rate of 14%. Anti-angiogenic therapy through anti-VEGF antibody administration is one of the l...

    Johannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas in Molecular Cancer (2023)

  7. Article

    Open Access

    Incidence and impact of new-onset postoperative arrhythmia after surgery of the lower gastrointestinal tract

    Postoperative arrhythmias (PAs) are common events and have been widely investigated in cardiothoracic surgery. Within visceral surgery, a recent study revealed a significant occurrence of PA in esophageal rese...

    Felix Rühlmann, Mara Sophie Hedicke, Deborah Engelhardt in Scientific Reports (2023)

  8. No Access

    Living Reference Work Entry In depth

    Rektumkarzinom: Radikale operative Therapie

    Die Therapie des Rektumkarzinoms ist sehr komplex und häufig eingebunden in interdisziplinäre Behandlungskonzepte. Während ein T1-Karzinom ohne Risikofaktoren und ohne Hinweis auf Lymphknotenmetastasen lokal e...

    Marian Grade, Michael Ghadimi in Viszeral- und Allgemeinchirurgie

  9. Article

    Open Access

    Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry

    Non-resectability is common in patients with pancreatic ductal adenocarcinoma (PDAC) due to local invasion or distant metastases. Then, biliary or gastroenteric bypasses or both are often established despite a...

    Felix O. Hofmann, Rainer C. Miksch, Maximilian Weniger, Tobias Keck in BMC Surgery (2022)

  10. Article

    Open Access

    Treatment options of metastatic and nonmetastatic VIPoma: a review

    VIPoma belongs to the group of neuroendocrine neoplasms. These tumours are located mostly in the pancreas and produce high levels of vasoactive intestinal peptide (VIP). In most cases, a metastatic state has a...

    Azadeh Azizian, Alexander König, Michael Ghadimi in Langenbeck's Archives of Surgery (2022)

  11. Article

    Open Access

    Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy

    Preoperative (neoadjuvant) chemoradiotherapy (CRT) and total mesorectal excision is the standard treatment for rectal cancer patients (UICC stage II/III). Up to one-third of patients treated with CRT achieve a...

    Georg Emons, Noam Auslander, Peter Jo, Julia Kitz in British Journal of Cancer (2022)

  12. Article

    Open Access

    Needle tract seeding and abdominal recurrence following pre-treatment biopsy of gastrointestinal stromal tumors (GIST): results of a systematic review

    Gastrointestinal stromal tumors (GIST) are rare abdominal tumors. Pretreatment biopsies may be used to diagnose a GIST and enable tailored treatment. Some experts are skeptical about biopsies because they fear...

    Jens Jakob, Rashad Salameh, David Wichmann, Nicos Charalambous in BMC Surgery (2022)

  13. Article

    Open Access

    Assessment of esophagogastric junction morphology by dynamic real-time MRI: comparison of imaging features to high-resolution manometry

    To assess the esophagogastric junction (EGJ) on real-time MRI and compare imaging parameters to EGJ morphology on high-resolution manometry (HRM).

    Lorenz Biggemann, Johannes Uhlig, Nina Gliem in Japanese Journal of Radiology (2022)

  14. No Access

    Article

    Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“

    Prof. Dr. med. Ralf Hofheinz, Dirk Arnold, Stefan Fichtner-Feigl in Der Onkologe (2022)

  15. Article

    International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    Multimodal treatment strategies for patients with rectal cancer are increasingly including the possibility of organ preservation, through nonoperative management or local excision. Organ preservation strategie...

    Emmanouil Fokas, Ane Appelt, Robert Glynne-Jones in Nature Reviews Clinical Oncology (2021)

  16. Article

    Open Access

    RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease

    Despite the identification of several genetic factors linked to increased susceptibility to inflammatory bowel disease (IBD), underlying molecular mechanisms remain to be elucidated in detail. The ubiquitin li...

    Robyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat in Cell Death & Differentiation (2021)

  17. No Access

    Article

    Einfluss der Molekularpathologie auf die onkologische Chirurgie des kolorektalen Karzinoms

    Das kolorektale Karzinom (KRK) ist noch immer eine der häufigsten Krebserkrankungen und eines der auf molekularer Ebene am besten charakterisierten Malignome. Interdisziplinäre sowie multimodale Behandlungsstr...

    Dr. med. Stefanie Nöpel-Dünnebacke, Lena-Christin Conradi in Der Chirurg (2021)

  18. Article

    Open Access

    Chirurgische Therapie des Ösophaguskarzinoms – Qualitätsindikatoren für Diagnostik und Therapie

    Im Rahmen der Qualitätsinitiative der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) wurde eine Übersichtsarbeit auf der Grundlage einer systematischen Literatursuche verfasst und Empfehlun...

    Prof. Dr. med. Jens Hoeppner, Patrick Sven Plum, Heinz Buhr, Ines Gockel in Der Chirurg (2021)

  19. No Access

    Article

    Chirurgische Resektion: offen, laparoskopisch, robotisch

    Bei einem Großteil der Patienten mit Rektumkarzinom wird der Tumor minimal-invasiv reseziert, in der chirurgischen Therapie des Kolonkarzinoms überwiegt aber noch die offene Resektionstechnik.

    Maximilian von Heesen MD, Michael Ghadimi in Der Onkologe (2021)

  20. No Access

    Article

    Klinische Komplettremission beim Rektumkarzinom: Wann ist weniger mehr?

    Nach neoadjuvanter Radiochemotherapie (RCT) wird bei 10–20 % der Patienten mit lokal fortgeschrittenem Rektumkarzinom eine pathologische Komplettremission nachgewiesen.

    Prof. Dr. Claus Rödel, Markus Diefenhardt, Emmanouil Fokas, Cihan Gani in Forum (2021)

previous disabled Page of 3